McIntyre, S. M. H., Preston, W., Walch, H. S., Sigel, C. S., Sharib, J., Chen, W., … Jarnagin, W. R. (2023). Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41, pp. 604–604).

McIntyre, Sarah Margaret Helena, William Preston, Henry S. Walch, Carlie S. Sigel, Jeremy Sharib, Wei Chen, Michael Lidsky, et al. “Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing.” In JOURNAL OF CLINICAL ONCOLOGY, 41:604–604, 2023.

McIntyre SMH, Preston W, Walch HS, Sigel CS, Sharib J, Chen W, et al. Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing. In: JOURNAL OF CLINICAL ONCOLOGY. 2023. p. 604–604.

McIntyre, Sarah Margaret Helena, et al. “Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, 2023, pp. 604–604.

McIntyre SMH, Preston W, Walch HS, Sigel CS, Sharib J, Chen W, Lidsky M, Kundra R, Cercek A, Harding JJ, Abou-Alfa GK, Balachandran VP, Drebin JA, Soares K, Wei AC-C, Kingham TP, D’Angelica MI, Iacobuzio-Donahue CA, Schultz N, Jarnagin WR. Concordance in oncogenic alterations between primary and recurrent/metastatic cholangiocarcinoma pairs using targeted next-generation sequencing. JOURNAL OF CLINICAL ONCOLOGY. 2023. p. 604–604.